Related Experiment Videos
Benzodiazepine-GABAA receptor binding during absence seizures
M C Prevett1, A A Lammertsma, D J Brooks
1MRC Cyclotron Unit, Hammersmith Hospital, London, England, U.K.
Epilepsia
|June 1, 1995
Summary
This study found no changes in benzodiazepine (BZD) binding to GABA-A receptors during absence seizures. These findings suggest BZD binding sites are not primarily involved in absence seizure development.
Area of Science:
- Neuroscience
- Epilepsy Research
- Molecular Psychiatry
Background:
- The precise role of benzodiazepine (BZD)-gamma-aminobutyric acidA (GABAA) receptors in absence seizures remains unclear.
- Previous research has yielded inconclusive results regarding GABAA receptor involvement in the pathogenesis of this epilepsy type.
Purpose of the Study:
- To investigate the impact of absence seizures on the binding of flumazenil to the BZD site of the GABAA receptor.
- To determine if alterations in BZD-GABAA receptor binding occur during absence seizure activity.
Main Methods:
- Utilized [11C]flumazenil positron emission tomography (PET) in five patients with idiopathic generalized epilepsy (IGE).
- Scans were performed both at rest and during absence seizures.
- Compared regional cerebral time-activity curves with computational models accounting for cerebral blood flow (CBF) and binding variations.
Main Results:
- No significant changes in [11C]flumazenil binding were observed during absence seizures compared to rest.
- Results were consistent with prior studies showing normal interictal [11C]flumazenil binding in absence epilepsy.
Conclusions:
- The BZD binding site of the GABAA receptor does not appear to play a primary role in the pathogenesis of absence seizures.
- These findings contribute to understanding the neurobiological underpinnings of absence epilepsy.